Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Rubraca (rucaparib)
i
Other names:
AG 014699, AG 14699, AG-14699, AG014699, CO-338, PF 01367338, PF-01367338, PF-1367338
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(71)
News
Trials
Company:
Clovis, Pharma& Schweiz
Drug class:
PARP inhibitor
Related drugs:
‹
olaparib (342)
talazoparib (81)
niraparib (80)
ABT-888 (35)
pamiparib (18)
fluzoparib (12)
JPI-547 (7)
IMP4297 (6)
MK-4837 (3)
NOV 1401 (3)
SC10914 (2)
ABT-767 (1)
SBP-101 (1)
AMXI-5001 (0)
AZD2461 (0)
E7016 (0)
HWH340 (0)
TSL1502 (0)
[²¹¹At]PTT (0)
kt-3000 series (0)
kt-3283 (0)
SMOCL-9112 (0)
2X-121 (0)
olaparib (342)
talazoparib (81)
niraparib (80)
ABT-888 (35)
pamiparib (18)
fluzoparib (12)
JPI-547 (7)
IMP4297 (6)
MK-4837 (3)
NOV 1401 (3)
SC10914 (2)
ABT-767 (1)
SBP-101 (1)
AMXI-5001 (0)
AZD2461 (0)
E7016 (0)
HWH340 (0)
TSL1502 (0)
[²¹¹At]PTT (0)
kt-3000 series (0)
kt-3283 (0)
SMOCL-9112 (0)
2X-121 (0)
›
Associations
(71)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA1 mutation
Peritoneal Cancer
BRCA1 mutation
Peritoneal Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA2 mutation
Peritoneal Cancer
BRCA2 mutation
Peritoneal Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
BRCA1 mutation
Fallopian Tube Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
BRCA2 mutation
Fallopian Tube Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA1 mutation
Ovarian Cancer
BRCA1 mutation
Ovarian Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
No biomarker
Ovarian Cancer
No biomarker
Ovarian Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA1 mutation
Prostate Cancer
BRCA1 mutation
Prostate Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
BRCA2 mutation
Prostate Cancer
BRCA2 mutation
Prostate Cancer
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
rucaparib
Sensitive: A1 - Approval
rucaparib
Sensitive
:
A1
HRD
Ovarian Cancer
HRD
Ovarian Cancer
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
PALB2 mutation
Pancreatic Adenocarcinoma
PALB2 mutation
Pancreatic Adenocarcinoma
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
BRCA2 mutation
Pancreatic Adenocarcinoma
BRCA2 mutation
Pancreatic Adenocarcinoma
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
BRCA1 mutation
Pancreatic Adenocarcinoma
BRCA1 mutation
Pancreatic Adenocarcinoma
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
BRCA wild-type
Ovarian Cancer
BRCA wild-type
Ovarian Cancer
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
rucaparib
Sensitive: A2 - Guideline
rucaparib
Sensitive
:
A2
RAD51D mutation
Ovarian Cancer
RAD51D mutation
Ovarian Cancer
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
RAD51C mutation
Ovarian Cancer
RAD51C mutation
Ovarian Cancer
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
ATM mutation
Prostate Cancer
ATM mutation
Prostate Cancer
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
rucaparib
Sensitive: B - Late Trials
rucaparib
Sensitive
:
B
BRCA2 mutation
Non Small Cell Lung Cancer
BRCA2 mutation
Non Small Cell Lung Cancer
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA1 mutation
Non Small Cell Lung Cancer
BRCA1 mutation
Non Small Cell Lung Cancer
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA2 mutation
Pancreatic Cancer
BRCA2 mutation
Pancreatic Cancer
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA1 mutation
Pancreatic Cancer
BRCA1 mutation
Pancreatic Cancer
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA1 mutation
Mesothelioma
BRCA1 mutation
Mesothelioma
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA1 mutation
Triple Negative Breast Cancer
BRCA1 mutation
Triple Negative Breast Cancer
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA2 mutation
Gastrointestinal Cancer
BRCA2 mutation
Gastrointestinal Cancer
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA1 mutation
Gastrointestinal Cancer
BRCA1 mutation
Gastrointestinal Cancer
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
rucaparib
Sensitive: C1 - Off-label
rucaparib
Sensitive
:
C1
BRCA2 mutation
Triple Negative Breast Cancer
BRCA2 mutation
Triple Negative Breast Cancer
rucaparib
Resistant: C1 - Off-label
rucaparib
Resistant
:
C1
rucaparib
Resistant: C1 - Off-label
rucaparib
Resistant
:
C1
ATM mutation
Solid Tumor
ATM mutation
Solid Tumor
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
FANCA mutation
Prostate Cancer
FANCA mutation
Prostate Cancer
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
BRIP1 mutation
Prostate Cancer
BRIP1 mutation
Prostate Cancer
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
PALB2 mutation
Pancreatic Cancer
PALB2 mutation
Pancreatic Cancer
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
rucaparib
Sensitive: C2 – Inclusion Criteria
rucaparib
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login